Article citationsMore>>

Hollick, J.J., Golding, B.T., Hardcastle, I.R., Martin, N., Richardson, C., Rigoreau, L.J., Smith, G.C. and Griffin, R.J. (2003) 2,6-Disubstituted Pyran-4-One and Thiopyran-4-One Inhibitors of DNA-Dependent Protein Kinase (DNA-PK). Bioorganic & Medicinal Chemistry Letters, 13, 3083-3086.
https://doi.org/10.1016/S0960-894X(03)00652-8

has been cited by the following article:

• TITLE: Molecular Modeling and Synthesis of New Heterocyclic Compounds Containing Pyrazole as Anticancer Drugs

  AUTHORS: Fiby N. Takla, Abdelbasset A. Farahat, Magda A.-A. El-Sayed, Magda N. A. Nasr

  KEYWORDS: Tubulin, CA-4, Anticancer, Pyrazole, Molecular Modeling

  JOURNAL NAME: International Journal of Organic Chemistry, Vol.7 No.4, December 15, 2017

  ABSTRACT: Several modifications in CA-4 were reported in literature for the development of various tubulin inhibitors. In our study, twenty-two newly synthesized heterocyclic derivatives of Combretastatin A-4 (CA-4) have been tested for their cytotoxic effect on four different types of cells with malignant behavior using CA-4 as a positive control. Compounds 5b, 15 and 16 showed the foremost potent antiproliferative activities as compared to CA-4 with IC50 starting from 6.9 to 13.7 μM. Molecular docking was performed with the crystal structure of tubulin employing a potent tubulin inhibitor CA-4 as a parent molecule. Molecular study advised that 5b, 15, 16 and 17 are promising tubulin inhibitors.